Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials
4 pending office actions • 3 art units • 4 examiners • 0 of 4 (0%) have an AI response strategy ready
Florida Research Group LLC has 4 pending office actions in the Biotechnology & Pharmaceuticals technology area. These actions are located in 3 distinct art units, indicating that the 4 pending office actions span several specialized technical areas. The portfolio involves distinct examiners, which means that every pending action is being reviewed by a different person. This distribution requires the company to manage different examiner perspectives simultaneously.
KASSA, TIGABU is the busiest examiner, holding 1 pending office action. Since there are distinct examiners for 4 pending actions, each case is reviewed by a different person. The 3 distinct art units indicate that the pending office actions are being reviewed by different technical groups within the office. Practitioners should be prepared for different examiner styles while navigating the procedural requirements of the 3 distinct art units for the 4 pending office actions.
Based on the USPTO statutory response window for each pending office action. 3 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 3 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 3 (75%) |
| Multi-statute (no §101) | 1 (25%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| KASSA, TIGABU | 1 | 36.7% | +27.9% |
| PERREIRA, MELISSA JEAN | 1 | 52.1% | +25.7% |
| KERSHAW, KELLY P | 1 | 17.7% | +16.0% |
| MERCHLINSKY, JOSEPH CULLEN | 1 | 5.9% | -6.3% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18302171 | IMPROVED METHODS OF MAKING NON-AQUEOUS CHEWS | MERCHLINSKY, JOSEPH CULLEN | 20d |
| 18352393 | EASILY SPOONABLE PROTEIN-RICH SUPPLEMENT PASTE | KERSHAW, KELLY P | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18969629 | Stable Soft Chews, and Methods to Produce Same | PERREIRA, MELISSA JEAN | 26d overdue |
| 19018403 | Soft Chews with Low Water Activity and Methods of Manufacturing Same | KASSA, TIGABU | 71d |
| 18352393 | EASILY SPOONABLE PROTEIN-RICH SUPPLEMENT PASTE | KERSHAW, KELLY P | — |
| Art Unit | Apps |
|---|---|
| 1791 | 2 |
| 1619 | 1 |
| 1618 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19018403 | Soft Chews with Low Water Activity and Methods of Manufacturing Same | KASSA, TIGABU | 1619 | §103 | Final Rejection | 71d | Pending | Jan 13, 2025 |
| 18969629 | Stable Soft Chews, and Methods to Produce Same | PERREIRA, MELISSA JEAN | 1618 | §103 | Non-Final OA | 26d overdue | Pending | Dec 05, 2024 |
| 18352393 | EASILY SPOONABLE PROTEIN-RICH SUPPLEMENT PASTE | KERSHAW, KELLY P | 1791 | §103§112 | Non-Final OA | — | Pending | Jul 14, 2023 |
| 18302171 | IMPROVED METHODS OF MAKING NON-AQUEOUS CHEWS | MERCHLINSKY, JOSEPH CULLEN | 1791 | §103 | Non-Final OA | 20d | Pending | Apr 18, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialFlorida Research Group LLC has 4 pending office actions as of October 2026, spread across 3 art units and 4 examiners.
Tigabu Kassa has the most, with 1 of Florida Research Group LLC's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
